References
- BurrellCJ, HowardCR, MurphyFA. Epidemiology of viral infections. Fenner Whites Med Virol. 2017;185–203. doi:10.1016/B978-0-12-375156-0.00013-8
- CascellaM, RajnikM, CuomoA, DulebohnSC, Di NapoliR. Features, evaluation and treatment Coronavirus (COVID 19). StatPearls [Internet]; 2020. Available from:http://www.ncbi.nlm.nih.gov/pubmed/32150360. Accessed 923, 2021.
- GhebreyesusTA. WHO director-general’s opening remarks at the media briefing on COVID 19-11 March 2020 [Internet]. WHO Director General’s speeches; 2020:4. Available from:https://www.who.int/director-general/speeches/who-director-general-s-opening-remarks-at-the-media-briefing-on-COVID19—11-march-2020%0Ahttps://www.who.int/director-general/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-cov. Accessed 923, 2021.
- Johns Hopkins Coronavirus Resource Center. No title [Internet]; 2021 [cited July 13, 2021]. Available from: https://coronavirus.jhu.edu/map.html. Accessed 923, 2021.
- World Health Organization. Tracking SARS-CoV-2 variants [Internet]. Available from: https://www.who.int/en/activities/tracking-SARS-CoV-2-variants/. Accessed 923, 2021.
- WilliamsonEJ, WalkerAJ, BhaskaranK, et al. Factors associated with COVID 19-related death using OpenSAFELY. Nature. 2020;584(7821):430–436. doi:10.1038/s41586-020-2521-432640463
- SimonnetA, ChetbounM, PoissyJ, et al. High prevalence of obesity in Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) requiring invasive mechanical ventilation. Obesity. 2020;28(7):1195–1199. doi:10.1002/oby.2283132271993
- Centre for Disease Control and Prevention (CDC). COVID 19 [Internet]. Available from: https://www.cdc.gov/coronavirus/2019-ncov/need-extra-precautions/index.html. Accessed 923, 2021.
- SchlesingerS, NeuenschwanderM, BallonA, NöthlingsU, BarbareskoJ. Adherence to healthy lifestyles and incidence of diabetes and mortality among individuals with diabetes: a systematic review and meta-analysis of prospective studies. J Epidemiol Community Health. 2020;74(5):481–487. doi:10.1136/jech-2019-21341532075860
- NybergST, Singh-ManouxA, PenttiJ, et al. Association of healthy lifestyle with years lived without major chronic diseases. JAMA Intern Med. 2020;180(5):760–768. doi:10.1001/jamainternmed.2020.061832250383
- LiY, SchoufourJ, WangDD, et al. Healthy lifestyle and life expectancy free of cancer, cardiovascular disease, and type 2 diabetes: prospective cohort study. BMJ. 2020;368:l6669.31915124
- SimonsD, ShahabL, BrownJ, PerskiO. The association of smoking status with SARS-CoV-2 infection, hospitalisation and mortality from COVID 19: a living rapid evidence review (version 6). Qeios. 2020;116:1319–1368.
- World no tobacco day. Med Today. 2002;3:7. WHO: https://www.who.int/campaigns/world-no-tobacco-day
- World Health Organization. WHO Statement: Tobacco Use and COVID 19. WHO; 5, 2020:19–20.
- Centre for Disease Control and Prevention (CDC). People at Increased Risk of COVID 19; 2020:2019–2021.
- IgićR. Smoking and COVID 19. Vojnosanit Pregl. 2020;77:461–462. doi:10.2298/VSP2005461I
- Pötschke-LangerM, SchotteK, SzilagyiT. The WHO framework convention on tobacco control. Prog Respir Res. 2015;42:149–157.
- KimH, HegdeS, LaFiuraC, et al. COVID-19 illness in relation to sleep and burnout. BMJ Nutr Prev Health. 2021;4(1):132–139. doi:10.1136/bmjnph-2021-000228
- HamerM, KivimäkiM, GaleCR, BattyGD. Lifestyle risk factors, inflammatory mechanisms, and COVID 19 hospitalization: a community-based cohort study of 387,109 adults in UK. Brain Behav Immun. 2020;87:184–187. doi:10.1016/j.bbi.2020.05.05932454138
- International Centre for Diarrhoeal Disease Research Bangladesh. Non-communicable diseases. https://www.icddrb.org/research/research-themes/non-communicable-diseases
- NargisN, ThompsonME, FongGT, et al. Prevalence and patterns of tobacco use in Bangladesh from 2009 to 2012: evidence from International Tobacco Control (ITC) study. PLoS One. 2015;10(11):1–16. doi:10.1371/journal.pone.0141135
- FischerF, MinnwegenM, KaneiderU, KraemerA, KhanMMH. Prevalence and determinants of secondhand smoke exposure among women in Bangladesh, 2011. Nicotine Tob Res. 2015;17(1):58–65. doi:10.1093/ntr/ntu12925125322
- Coronavirus disease (COVID-2019) Bangladesh situation reports. https://www.who.int/bangladesh/emergencies/coronavirus-disease-(covid-19)-update/coronavirus-disease-(covid-2019)-bangladesh-situation-reports
- Bangladesh Society of Medicine. 2019-nCOV (SARS-COV-2) Infection Prevention Control (IPC) and Management in Healthcare Facilities; 2020.
- HoFK, Petermann-RochaF, GraySR, et al. Is older age associated with COVID 19 mortality in the absence of other risk factors? General population cohort study of 470,034 participants. PLoS One. 2020;15(11):e0241824. doi:10.1371/journal.pone.024182433152008
- BoehmerTK, DeViesJ, CarusoE, et al. Changing age distribution of the COVID 19 pandemic. MMWR Morb Mortal Wkly Rep. 2020;69(39):1404–1409. doi:10.15585/mmwr.mm6939e133001872
- CortisD. On determining the age distribution of COVID 19 pandemic. Front Public Health. 2020;8(May):1–3.32117846
- HarlemG. Descriptive analysis of social determinant factors in urban communities affected by COVID 19. J Public Health. 2020;42(3):466–469.
- DemeulemeesterF, de PunderK, van HeijningenM, van DoesburgF. Obesity as a risk factor for severe COVID 19 and complications: a review. Cells. 2021;10(4). doi:10.3390/cells10040933
- GaoF, ZhengKI, WangXB, et al. Obesity is a risk factor for greater COVID 19 severity. Diabetes Care. 2020;43(7):E72–E74. doi:10.2337/dc20-068232409499
- World Health Organization. Update: 31 July 2020. WHO; 7, 2020:1–203.
- BerlinI, ThomasD, Le FaouAL, CornuzJ. COVID 19 and smoking. Nicotine Tob Res. 2020;22(9):1650–1652. doi:10.1093/ntr/ntaa05932242236
- SanyaoluA, OkorieC, MarinkovicA, et al. Comorbidity and its impact on patients with COVID 19. SN Compr Clin Med. 2020;2(8):1069–1076. doi:10.1007/s42399-020-00363-4
- ZhouY, YangQ, ChiJ, et al. Comorbidities and the risk of severe or fatal outcomes associated with coronavirus disease 2019: a systematic review and meta-analysis. Int J Infect Dis. 2020;99:47–56. doi:10.1016/j.ijid.2020.07.02932721533
- WuJ, ZhangJ, SunX, et al. Influence of diabetes mellitus on the severity and fatality of SARS-CoV-2 (COVID 19) infection. Diabetes Obes Metab. 2020;22(10):1907–1914. doi:10.1111/dom.1410532496012
- NishigaM, WangDW, HanY, LewisDB, WuJC. COVID 19 and cardiovascular disease: from basic mechanisms to clinical perspectives. Nat Rev Cardiol. 2020;17(9):543–558. doi:10.1038/s41569-020-0413-932690910
- OrtizA, CozzolinoM, DuivenvoordenR, et al. Chronic kidney disease is a key risk factor for severe COVID 19: a call to action by the ERA-EDTA. Nephrol Dial Transplant. 2021;36(1):87–94. doi:10.1093/ndt/gfaa31433340043
- MohsinF, TonmonT, NahrinR, et al. Association between smoking and COVID 19 severity: evidence from Bangladesh. J Multidiscip Healthc. 2021;14:1923–1933. doi:10.2147/JMDH.S31760334326643
- ZhangJJ, DongX, CaoYY, et al. Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China. Allergy Eur J Allergy Clin Immunol. 2020;75(7):1730–1741. doi:10.1111/all.14238
- ZhouF, YuT, DuR, et al. Clinical course and risk factors for mortality of adult inpatients with COVID 19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395(10229):1054–1062. doi:10.1016/S0140-6736(20)30566-332171076
- CenY, ChenX, ShenY, et al. Risk factors for disease progression in patients with mild to moderate coronavirus disease 2019—a multi-centre observational study. Clin Microbiol Infect. 2020;26(9):1242–1247. doi:10.1016/j.cmi.2020.05.04132526275
- ZhaoQ, MengM, KumarR, et al. The impact of COPD and smoking history on the severity of COVID 19: a systemic review and meta-analysis. J Med Virol. 2020;92(10):1915–1921. doi:10.1002/jmv.2588932293753
- NewmanAB, EnrightPL, ManolioTA, HaponikEF, WahlPW. Sleep disturbance, psychosocial correlates, and cardiovascular disease in 5201 older adults: the Cardiovascular Health Study. J Am Geriatr Soc. 1997;45(1):1–7. doi:10.1111/j.1532-5415.1997.tb00970.x8994480
- VahidyFS, PanAP, AhnstedtH, et al. Sex differences in susceptibility, severity, and outcomes of coronavirus disease 2019: cross-sectional analysis from a diverse US metropolitan area. PLoS One. 2021;16(1):e0245556. doi:10.1371/journal.pone.024555633439908